Citigroup’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-857,481
| Closed | -$29.5M | – | 5410 |
|
|
2020
Q3 | $29.5M | Buy |
857,481
+773,452
| +920% | +$26.6M | 0.02% | 441 |
|
|
2020
Q2 | $1.4M | Buy |
84,029
+31,425
| +60% | +$525K | ﹤0.01% | 1867 |
|
|
2020
Q1 | $758K | Sell |
52,604
-9,284
| -15% | -$134K | ﹤0.01% | 2002 |
|
|
2019
Q4 | $2.07M | Sell |
61,888
-27,480
| -31% | -$920K | ﹤0.01% | 1646 |
|
|
2019
Q3 | $1.87M | Buy |
89,368
+64,545
| +260% | +$1.35M | ﹤0.01% | 1669 |
|
|
2019
Q2 | $517K | Buy |
24,823
+15,193
| +158% | +$316K | ﹤0.01% | 2646 |
|
|
2019
Q1 | $215K | Sell |
9,630
-60,616
| -86% | -$1.35M | ﹤0.01% | 3086 |
|
|
2018
Q4 | $1.68M | Buy |
70,246
+51,382
| +272% | +$1.23M | ﹤0.01% | 1639 |
|
|
2018
Q3 | $515K | Buy |
18,864
+112
| +0.6% | +$3.06K | ﹤0.01% | 2504 |
|
|
2018
Q2 | $504K | Sell |
18,752
-5,621
| -23% | -$151K | ﹤0.01% | 2344 |
|
|
2018
Q1 | $776K | Sell |
24,373
-16,914
| -41% | -$539K | ﹤0.01% | 1987 |
|
|
2017
Q4 | $1.56M | Buy |
41,287
+14,407
| +54% | +$545K | ﹤0.01% | 1615 |
|
|
2017
Q3 | $667K | Buy |
26,880
+3,986
| +17% | +$98.9K | ﹤0.01% | 2218 |
|
|
2017
Q2 | $471K | Buy |
22,894
+9,330
| +69% | +$192K | ﹤0.01% | 2459 |
|
|
2017
Q1 | $294K | Sell |
13,564
-35,743
| -72% | -$775K | ﹤0.01% | 2734 |
|
|
2016
Q4 | $1.01M | Buy |
49,307
+46,511
| +1,663% | +$951K | ﹤0.01% | 2383 |
|
|
2016
Q3 | $42K | Sell |
2,796
-300
| -10% | -$4.51K | ﹤0.01% | 3832 |
|
|
2016
Q2 | $33K | Sell |
3,096
-6,107
| -66% | -$65.1K | ﹤0.01% | 3924 |
|
|
2016
Q1 | $124K | Buy |
9,203
+4,380
| +91% | +$59K | ﹤0.01% | 3823 |
|
|
2015
Q4 | $89K | Buy |
4,823
+4,466
| +1,251% | +$82.4K | ﹤0.01% | 3667 |
|
|
2015
Q3 | $9K | Buy |
+357
| New | +$9K | ﹤0.01% | 4451 |
|